Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivoAndrew W Hudacek, Fetweh H Al-Saleem, Mallory Willet, et al.
Cell Reports|July 23, 2020
Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across PhylogroupsChristine R Fisher, David E Lowe, Todd G Smith, et al.
Nature Communications|October 13, 2018
Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa feverTiago Abreu-Mota, Katie R Hagen, Kurt Cooper, et al.
The Journal of Infectious Diseases|September 22, 2009
Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primatesJonathan Cenna, Meredith Hunter, Gene S Tan, et al.
Emerging Microbes & Infections|January 20, 2026
Immunogenicity and Efficacy of a Rabies-Based Vaccine against Highly Pathogenic Influenza H5N1 VirusNir Paran, Christoph Wirblich, Randy Albrecht, et al.
Virology|July 6, 2006
Rabies virus glycoprotein as a carrier for anthrax protective antigenMary Ellen Smith, Martin Koser, Sa Xiao, et al.
Neuron|January 26, 2016
Rabies Virus CVS-N2c(ΔG) Strain Enhances Retrograde Synaptic Transfer and Neuronal ViabilityThomas R Reardon, Andrew J Murray, Gergely F Turi, et al.
Pageof 12